Ask Warren

Green Lifescience

114450 · KOSDAQ · ₩114450 · 그린생명과학

₩2,030▼ ₩100 (4.69%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩19B₩16B₩13B₩11B₩11B₩4.9B₩7B₩4.5B
Cost of sales₩17B₩14B₩11B₩11B₩11B₩5.4B₩6.6B₩4.5B
Gross profit₩2.4B₩1.1B₩1.8B₩732M₩516M−₩533M₩399M−₩97M
Operating income₩1.8B₩585M₩1.2B₩105M₩13M−₩1.1B−₩432M−₩627M
Net income₩2.6B₩1.8B−₩380M₩454M₩1.2B−₩1.1B₩2.7B−₩2.4B
Net income to shareholders₩2.6B₩1.8B−₩380M₩454M₩1.2B−₩1.1B₩2.7B−₩2.4B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩59B₩56B₩55B₩50B₩46B₩45B₩45B₩43B
Current assets₩36B₩33B₩33B₩27B₩23B₩22B₩22B₩20B
Cash and equivalents₩14B₩10B₩13B₩10B₩7.4B₩8.7B₩9.1B₩7.5B
Total liabilities₩15B₩16B₩17B₩15B₩11B₩10B₩9.2B₩7.5B
Current liabilities₩12B₩15B₩16B₩14B₩10B₩9.3B₩8.3B₩6.9B
Borrowings₩5.5B₩4.8B₩6.5B₩6.6B₩7.3B₩4.8B₩4.8B₩4.8B
Total equity₩45B₩40B₩38B₩35B₩35B₩35B₩36B₩36B
Shareholders' equity₩45B₩40B₩38B₩35B₩35B₩35B₩36B₩36B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩3.3B−₩2.6B₩332M₩3.3B−₩3B−₩258M−₩1.2B₩1.8B
Capital spending₩540M₩144M₩503M₩81M₩166M₩109M−₩138M₩367M
Free cash flow₩2.8B−₩2.7B−₩172M₩3.2B−₩3.2B−₩367M−₩1.3B₩1.4B

Consolidated where available. Amounts in won.

Also known as: Green Lifescience / 그린생명과학 / 114450 / KRX:114450

Source: KRX statistical information